A new Indian medical technology company is prepared to dominate the international market. Through the purchase of the majority stake in Avra Medical Robotics, a Nasdaq-listed business in the United States, India’s SS Innovations has now obtained access to the global capital & market. It is important to note that the brilliant SSI Mantra, the creation of internationally renowned robotic heart surgeon Dr. Sudhir P Srivastava, has ushered in a new era of surgical techniques in India by making robotic surgery available and reasonably priced for the people of our nation. All people will have access to high-quality healthcare instead of it being a privilege for a select few!

The “Guest of Honor” at the announcement program was Dr. Frederic Moll, the father of robotic surgery. The world’s first surgical robot, the Da Vinci surgical system, was founded by Dr. Moll, a well-known medical equipment developer and businessman who specializes in robotic surgery. He emphasized the value of robotic surgery and its several advantages over conventional surgical techniques.

Being the first firm in South Asia to introduce the first totally “Made in India” surgical robot, the SSI Mantra, a highly developed surgical robotic system with more and better capabilities and applications than current systems, SS Innovations has brought honor to the country. In terms of accuracy, technological advancement, and cost containment, this device will completely alter the concept of surgical procedures both in our country and around the globe, making expensive robotic surgery accessible to the general public.

On the occasion of this significant announcement, Bryan Knodel, a highly skilled and experienced medical robotics scientist, and Barry F Cohen, the founder, chairman, and CEO of Avra Medical Robotics Inc., USA, were also present.

With an initial emphasis on aesthetics, Avra Medical Robotics is driving the change in healthcare from assistive to semi-autonomous therapies. The business is always developing semi-autonomous systems. With the Avra Robotic Treatment System (ARTS), healthcare professionals can read a treatment plan and observe as the robot handles all other aspects of the procedure. Their method has limitless diagnostic and therapeutic implications for the healthcare industry to target, diagnose, and treat through precision scanning, artificial intelligence, treatment, and information collection.

Through this merger, a new era in healthcare will soon be realized, revolutionizing robotic surgery around the world.